Naturalistic, retrospective comparison between antidepressant therapy and atypical antipsychotic augmentation therapy for patients with major depressive disorder

被引：0
|
作者：
Cho, Se Hoon [1 ]
Jae, Young Myo [1 ]
Jang, Sae Heon [1 ]
Baek, Dae Up [2 ]
Choi, Jin Hyuk [1 ]
机构：
[1] Bong Seng Mem Hosp, Dept Psychiat, Busan, South Korea
[2] Dongrae Bong Seng Mem Hosp, Dept Psychiat, Busan, South Korea
来源：
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY | 2016年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
PS78
引用
收藏
页码：73 / 74
页数：2
相关论文
共 50 条
  • [21] Atypical Antipsychotic Augmentation Strategies in the Context of Guideline-based Care for the Treatment of Major Depressive Disorder
    Ashwin A. Patkar
    Chi-Un Pae
    [J]. CNS Drugs, 2013, 27 : 29 - 37
  • [22] Atypical Antipsychotic Augmentation Strategies in the Context of Guideline-based Care for the Treatment of Major Depressive Disorder
    Patkar, Ashvvin A.
    Pae, Chi-Un
    [J]. CNS DRUGS, 2013, 27 : S29 - S37
  • [23] Aripiprazole augmentation, antidepressant combination or switching therapy in patients with major depressive disorder who are partial- or non-responsive to current antidepressants: A multi-center, naturalistic study
    Han, Changsu
    Wang, Sheng-Min
    Seo, Ho-Jun
    Lee, Boung Chul
    Jeon, Hong Jin
    Kim, Won
    Kwak, Kyung-Phil
    Pae, Chi-Un
    [J]. JOURNAL OF PSYCHIATRIC RESEARCH, 2014, 49 : 75 - 82
  • [24] Aripiprazole augmentation, antidepressant combination or switching therapy in patients with major depressive disorder who are partial- or non-responsive to current antidepressants: A multi-center, naturalistic study
    Pae, C. -U.
    Ahn, S.
    Han, C.
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2014, 17 : 138 - 138
  • [25] CNS Drugs Optimizing Outcomes in Major Depressive Disorder via Augmentation Therapy - Focus on the Role of Atypical Antipsychotics
    [J]. CNS Drugs, 2013, 27 (Suppl 1) : 1 - 1
  • [26] Antidepressant Effect of Combined Ketamine and Electroconvulsive Therapy on Patients With Major Depressive Disorder: A Randomized Trial
    Alizadeh, Narges
    Maroufi, Azad
    Nasseri, Karim
    Najafabadi, Seyed
    Taghiabad, Ali
    Gharibi, Fardin
    Esfandiari, Gholam
    [J]. IRANIAN JOURNAL OF PSYCHIATRY AND BEHAVIORAL SCIENCES, 2015, 9 (03)
  • [27] Effects of adjunctive aripiprazole in patients with major depressive disorder with inadequate response to standard antidepressant therapy
    Lee, J. S.
    Kim, S. G.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2017, 27 : S865 - S866
  • [28] Effect of antidepressant therapy on white matter in patients with first-episode major depressive disorder
    Lee, Chun-Te
    Lai, Te-Jen
    Hsieh, Ming-Hong
    Wu, Ming-Chi
    Chang, Cheng-Chen
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2016, 19 : 73 - 73
  • [29] Long-term safety and tolerability of open-label aripiprazole augmentation of antidepressant therapy in major depressive disorder
    Berman, Robert M.
    Thase, Michael E.
    Trivedi, Madhukar H.
    Hazel, James A.
    Marler, Sabrina Vogel
    McQuade, Robert D.
    Carson, William
    Baker, Ross A.
    Marcus, Ronald N.
    [J]. NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2011, 7 : 303 - 312
  • [30] Major depressive disorder after heart transplantation with partial response to antidepressant therapy and remission with aripiprazole augmentation: A case report
    Nakamura, Toshinori
    Kuraishi, Yuta
    Ohya, Dai
    Kimura, Kazuhiro
    Sasayama, Daimei
    Washizuka, Shinsuke
    [J]. NEUROPSYCHOPHARMACOLOGY REPORTS, 2024,
12345